Table 2.
Results of risk factors analysis of lost to follow up in TB patients.
| Variables | n | Rate of Lost to follow up (per 1000 TB) | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|---|---|
| OR (95%CI) | P-value | OR (95%CI) | P-value | |||
| Gender | ||||||
| Males | 2443 | 102.73 | Referent | Referent | ||
| Females | 972 | 40.87 | 0.77 (0.71–0.83) | < 0.001 | 0.78 (0.72–0.84) | < 0.001 |
| Age | ||||||
| 0~ | 382 | 16.06 | Referent | Referent | ||
| 20~ | 1155 | 48.57 | 1.17 (1.04–1.32) | 0.008 | 1.18 (1.04–1.35) | 0.009 |
| 40~ | 1015 | 42.68 | 1.04 (0.93–1.17) | 0.485 | 1.06 (0.93–1.20) | 0.43 |
| 60~ | 863 | 36.29 | 1.04 (0.92–1.17) | 0.578 | 1.13 (0.99–1.30) | 0.076 |
| Nationality | ||||||
| Han | 2420 | 101.76 | Referent | Referent | ||
| Miao | 450 | 18.92 | 1.02 (0.92–1.13) | 0.689 | 1.04 (0.94–1.15) | 0.461 |
| Buyi | 163 | 6.85 | 0.56 (0.48–0.66) | < 0.001 | 0.57 (0.48–0.67) | < 0.001 |
| Yi | 200 | 8.41 | 1.95 (1.68–2.23) | < 0.001 | 1.82 (1.57–2.11) | < 0.001 |
| Dong | 53 | 2.23 | 0.39 (0.30–0.51) | < 0.001 | 0.39 (0.29–0.51) | < 0.001 |
| Tujia | 37 | 1.56 | 0.20 (0.15–0.28) | < 0.001 | 0.22 (0.16–0.30) | < 0.001 |
| Others | 92 | 3.87 | 0.71 (0.57–0.87) | 0.001 | 0.71 (0.58–0.87) | 0.001 |
| Occupation | ||||||
| Peasant workers | 2787 | 117.20 | Referent | Referent | ||
| Homemakers and unemployed persons | 192 | 8.07 | 1.18 (1.02–1.37) | 0.026 | 1.12 (0.96–1.30) | 0.148 |
| Students | 283 | 11.90 | 1.01 (0.90–1.15) | 0.843 | 1.07 (0.93–1.23) | 0.323 |
| Retired persons and cadres and staff | 36 | 1.51 | 0.54 (0.39–0.76) | < 0.001 | 0.56 (0.41–0.79) | 0.001 |
| Others | 117 | 4.92 | 0.83 (0.69–1.01) | 0.056 | 0.81 (0.67–0.98) | 0.027 |
| Local registered residence | ||||||
| Yes | 3067 | 128.97 | Referent | Referent | ||
| No | 348 | 14.63 | 1.02 (0.91–1.14) | 0.728 | 1.18 (1.05–1.32) | 0.005 |
| Source of patients | ||||||
| Clinical consultation | 1777 | 74.72 | Referent | Referent | ||
| Referral | 1065 | 44.78 | 0.87 (0.81–0.94) | < 0.001 | 0.85 (0.79–0.92) | < 0.001 |
| Following up | 382 | 16.06 | 0.59 (0.53–0.66) | < 0.001 | 0.59 (0.52–0.66) | < 0.001 |
| Recommended for symptoms | 71 | 2.99 | 1.00 (0.79–1.27) | 0.980 | 0.90 (0.71–1.15) | 0.411 |
| Physical examinations | 73 | 3.07 | 0.83 (0.65–1.05) | 0.112 | 0.87 (0.69–1.11) | 0.268 |
| Others | 47 | 1.98 | 1.01 (0.75–1.35) | 0.949 | 1.06 (0.79–1.42) | 0.705 |
| Clinical classification | ||||||
| Type I | 0 | 0.00 | Referent | Referent | ||
| Type II | 62 | 2.61 | 0.00 | 0.996 | 0.00 | 0.996 |
| Type III | 3109 | 130.74 | 1.62 (0.65–4.05) | 0.301 | 2.71 (1.06–6.93) | 0.038 |
| Type IV | 239 | 10.05 | 1.43 (0.59–3.46) | 0.424 | 2.74 (1.11–6.79) | 0.029 |
| Type V | 5 | 0.21 | 4.30 (1.76–10.47) | 0.001 | 3.93 (1.61–9.60) | 0.003 |
| Diagnosis | ||||||
| Etiological positivity | 1109 | 46.63 | Referent | Referent | ||
| Etiological negative | 2083 | 87.59 | 0.90 (0.84–0.97) | 0.007 | 1.06 (0.98–1.15) | 0.142 |
| Pure tuberculous pleurisy | 205 | 8.62 | 3.53 (3.03–4.11) | < 0.001 | 3.28 (2.51–4.30) | < 0.001 |
| Others | 18 | 0.76 | 1.62 (1.01–2.59) | 0.045 | 2.34 (1.45–3.77) | < 0.001 |
| Severe cases | ||||||
| Yes | 652 | 27.42 | Referent | Referent | ||
| No | 2763 | 116.19 | 0.68 (0.62–0.74) | < 0.001 | 0.67 (0.62–0.74) | < 0.001 |
| Therapeutic category | ||||||
| Initial treatment | 2965 | 124.68 | Referent | Referent | ||
| Re-treated | 450 | 18.92 | 2.29 (2.07–2.53) | < 0.001 | 2.17 (1.96–2.42) | < 0.001 |